(Mercaptoethyl)ammonium hydrogen tartrate
CAS: 27761-19-9
Ref. 3D-FM171255
1g | A consultar | ||
2g | A consultar | ||
5g | A consultar | ||
250mg | A consultar | ||
500mg | A consultar |
Informação sobre produto
- 2,3-Dihydroxybutanedioate
- 2-Aminoethanethiol
- Cystagon
- Cysteamine Bitartrate
- Ethanethiol, 2-amino-, (2R,3R)-2,3-dihydroxybutanedioate (1:1)
- Ethanethiol, 2-amino-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt)
- Ethanethiol, 2-amino-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt)
- Ethanethiol, 2-amino-, hydrogen tartrate
- Ethanethiol, 2-amino-, tartrate (1:1) (salt)
- Mercamine bitartrate
- Ver mais sinónimos
- Mercaptoethylamine bitartrate
- Procysbi
- Rp 103
- Rp 104
- β-Mercaptoethylamine bitartrate
- β-Mercaptoethylamine hydrogen tartrate
- β-Mercaptoethylamine hydrotartrate
The experimental model of the controlled-release preparation of (mercaptoethyl)ammonium hydrogen tartrate is based on the hypothesis that a high resistance to hepatic steatosis can be achieved by a prolonged release of cysteamine. The drug was administered enterically, and it was found that the concentration in the portal vein is higher than in the portal vein. Cysteamine enters into liver cells and inhibits protein synthesis. Cysteamine has been shown to have an effect on infectious diseases such as cystinosis, and sodium citrate reduces the toxicity of cysteamine.
Propriedades químicas
Consulta técnica sobre: 3D-FM171255 (Mercaptoethyl)ammonium hydrogen tartrate
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.